| Classifica | Nome della clinica | Valutazione dei pazienti | Paese | Medico principale | esperienza | Tecniche | Migliore per | Perché è in classifica | Accreditamenti |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 4.6 / 5 (514 recensioni) | Istanbul, Turkey | 33+ anni | Bacillus Calmette-Guérin (BCG) therapy, Immunotherapy with Keytruda (Pembolizumab), Immunotherapy for prostate cancer, Immunotherapy for lung cancer, Immunotherapy for breast cancer, Immunotherapy for kidney cancer, Sarcoma Immunotherapy | Patients needing personalized immunotherapy for various cancers | Anadolu Medical Center offers a wide range of immunotherapy treatments with experienced oncologists specializing in targeted therapies. Affiliated with Johns Hopkins Medicine and accredited by ESMO and JCI, ensuring high-quality care. | International Organization for Standardization, Joint Commission International | ||
| #2 | 5.0 / 5 (53 recensioni) | Istanbul, Turkey | 17+ anni | Immunotherapy with Keytruda (Pembrolizumab), CAR T-cell therapy | Advanced or metastatic cancers | Offers specialized immunotherapy treatments including Keytruda and CAR T-cell therapy. JCI and ISO accredited with a team of experienced oncologists. | Joint Commission International , International Organization for Standardization | ||
| #3 | 4.5 / 5 (155 recensioni) | Tel Aviv, Israel | 41+ anni34,000+ trattamenti | Biological therapy, Immunotherapy with Keytruda (Pembolizumab), Immunotherapy for prostate cancer, Immunotherapy for lung cancer, Immunotherapy for breast cancer, Immunotherapy for kidney cancer, CAR T-cell therapy, Sarcoma Immunotherapy | Advanced or metastatic cancers | Offers a wide range of immunotherapy options, including CAR T-cell therapy and Keytruda. JCI accredited with a 90% success rate in cancer treatment. Research-focused team with access to clinical trials. | World's Best Smart Hospitals 2021 by Newsweek, World's Best Hospitals 2021 by Newsweek | ||
| #4 | 4.6 / 5 (66 recensioni) | Milan, Italy | — | 8,000+ trattamenti | Immunotherapy with Keytruda (Pembolizumab), Immunotherapy for breast cancer, CAR T-cell therapy | Complex cancer cases | Multidisciplinary team including immunologists and oncologists. Specializes in personalized immunotherapy plans, including CAR T-cell therapy. Clinic performs over 52,000 operations annually. | Scientific Institute for Research and Healthcare Accrediatation, World's Best Hospitals 2021 by Newsweek | |
| #5 | 4.9 / 5 (53 recensioni) | Istanbul, Turkey | 23+ anni | Immunotherapy with Keytruda (Pembrolizumab), Immunotherapy for prostate cancer, Immunotherapy for lung cancer, Immunotherapy for breast cancer, Immunotherapy for kidney cancer | Personalized cancer care with immunotherapy | Specializes in tailored immunotherapy treatments with a multidisciplinary approach. Doctors have performed 900+ treatments with a focus on lung, breast, and gastrointestinal cancers. | Turkish Medical Association, International Health Tourism Authorization Certificate | ||
| #6 | 4.7 / 5 (154 recensioni) | Vienna, Austria | 44+ anni | Immunotherapy for breast cancer, CAR T-cell therapy | Advanced or hard-to-treat cancers | Offers personalized immunotherapy treatments combined with targeted therapy and chemotherapy. Led by Prof. Christoph Zielinski, a global leader in cancer immunotherapy with over 600 published papers. 95% treatment success rate. | International Organization for Standardization, World's Best Hospitals 2021 by Newsweek | ||
| #7 | 4.7 / 5 (440 recensioni) | Barcelona, Spain | 26+ anni23,000+ trattamenti | Immunotherapy with Keytruda (Pembolizumab), CAR T-cell therapy, Immunotherapy for prostate cancer, Immunotherapy for lung cancer, Immunotherapy for breast cancer, Immunotherapy for kidney cancer, Sarcoma Immunotherapy | Multiple cancer types with tailored immunotherapy | Offers 10+ immuno-drugs for personalized treatment plans. JCI accredited with 95% patient recommendation rate. 1,100,000+ patients treated. | Joint Commission International , European Foundation for Quality Management | ||
| #8 | 3.0 / 5 (1 recensioni) | Beijing, China | — | — | Immunotherapy | — | — | — | |
| #9 | 4.7 / 5 (354 recensioni) | Istanbul, Turkey | 25+ anni | Biological therapy, Immunotherapy with Keytruda (Pembrolizumab), CAR T-cell therapy, Immunotherapy for prostate cancer, Immunotherapy for lung cancer, Immunotherapy for breast cancer, Immunotherapy for kidney cancer | Targeted cancer immunotherapy | Offers multiple immunotherapy options including Keytruda and CAR T-cell therapy. JCI-accredited with oncology department following international NCCN and ESMO protocols. Specializes in personalized immunotherapy based on genetic markers. | International Organization for Standardization, Joint Commission International | ||
| #10 | 3.8 / 5 (8 recensioni) | Vienna, Austria | 20+ anni | Immunotherapy | — | — | — |